These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 566830)

  • 41. The effect of amantadine HCl on haloperidol-induced striatal dopamine neuron hypersensitivity.
    Allen RM; Flemenbaum A
    Biol Psychiatry; 1979 Jun; 14(3):541-4. PubMed ID: 573144
    [No Abstract]   [Full Text] [Related]  

  • 42. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
    Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
    Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differentiation of the central dopaminergic stimulants apomorphine and lergotrile.
    Wade RL; Krewsun I; Quock RM
    Proc West Pharmacol Soc; 1979; 22():141-2. PubMed ID: 42079
    [No Abstract]   [Full Text] [Related]  

  • 44. Animal models for tardive dyskinesia: effects of thioridazine.
    Sayers AC; Bürki HR; Ruch W; Asper H
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):291-5. PubMed ID: 616929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tardive dyskinesia: a biological appraoch.
    Barbaccia ML; Trabucchi M
    Prog Clin Biol Res; 1980; 39():181-93. PubMed ID: 6105670
    [No Abstract]   [Full Text] [Related]  

  • 46. Choline chloride in methylphenidate- and apomorphine-induced stereotypy.
    Davis KL; Hollister LE; Vento AL; Simonton S
    Life Sci; 1978 Jun; 22(24):2171-7. PubMed ID: 566835
    [No Abstract]   [Full Text] [Related]  

  • 47. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
    Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
    Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors.
    Globus M; Lerer B; Hamburger R; Belmaker RH
    Neuropharmacology; 1981 Nov; 20(11):1125-8. PubMed ID: 7198723
    [No Abstract]   [Full Text] [Related]  

  • 49. [Effect of arachidonic acid on stereotyped behavior in the rabbit induced by a dopamine receptor agonist].
    Kurchikov AL; Podol'skiĭ IIa; Bobylev RV; Ivanov VP
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(4):783-5. PubMed ID: 3931383
    [No Abstract]   [Full Text] [Related]  

  • 50. Blockade of lergotrile or apomorphine induced turning behavior by haloperidol and clozapine.
    Nakamura S; Engel J; Goldstein M
    Commun Psychopharmacol; 1978; 2(3):185-90. PubMed ID: 29742
    [No Abstract]   [Full Text] [Related]  

  • 51. D1 receptors mediated vacuous chewing in the rat: a model of tardive dyskinesia.
    Diana M; Collu M
    Pharmacol Res; 1990; 22 Suppl 3():45. PubMed ID: 2097639
    [No Abstract]   [Full Text] [Related]  

  • 52. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of dopamine agonists in tardive dyskinesia.
    Smith RC; Tamminga CA; Haraszti J; Pandey GN; Davis JM
    Am J Psychiatry; 1977 Jul; 134(7):763-8. PubMed ID: 869053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig.
    Weiner WJ; Carvey P; Nausieda PA; Goetz CG; Klawans HL
    Life Sci; 1981 May; 28(19):2173-8. PubMed ID: 7195969
    [No Abstract]   [Full Text] [Related]  

  • 55. Electrophysiological and behavioral assessments of dopamine autoreceptor activation to apomorphine in rats.
    Okuyama S; Shimamura H; Hashimoto S; Aihara H
    Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):246-54. PubMed ID: 3827410
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Anticholinergics promote neuroleptic-induced tardive dyskinesia.
    Borison RL; Diamond BI
    Adv Biochem Psychopharmacol; 1980; 24():359-61. PubMed ID: 6105786
    [No Abstract]   [Full Text] [Related]  

  • 57. Receptor-cell sensitivity modification (RSM) as a model for pathogenesis and treatment of tardive dyskinesia.
    Friedhoff AJ; Rosengarten H; Bonnet K
    Psychopharmacol Bull; 1978 Oct; 14(4):77-9. PubMed ID: 704769
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of tardive dyskinesia with choline and tetrabenazine.
    Snell AP; Cleary M; Sambrook M
    Postgrad Med J; 1980 Sep; 56(659):663-4. PubMed ID: 7465478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
    Broekkamp CL
    Life Sci; 1982 Dec; 31(25):2913-20. PubMed ID: 6891741
    [No Abstract]   [Full Text] [Related]  

  • 60. Molindone and haloperidol in tardive dyskinesia.
    Glazer WM; Hafez HM; Benarroche CL
    J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):4-7. PubMed ID: 2862139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.